Savills Expects High Demand for Centrally Located Facility

T3 Advisors, a Savills Company, recently announced the opportunity to acquire the fee simple interest of a biomanufacturing facility located at 8800 Health Science Center Pkwy. in Bryan. iBio, a developer of next-generation biopharmaceuticals, is seeking a forward-thinking landlord or developer to obtain ownership in its newly acquired and globally recognized manufacturing facility in the rapidly growing Texas Research Triangle, equidistant from Austin, Dallas and Houston.

The company purchased the facility it previously operated under a lease in November. In total, the site encompasses 36 acres including iBio’s two-story 139,000-square-foot manufacturing facility.

The facility was commissioned in 2011 and is one of the largest plant-producing and cGMP-approved biologics facilities in the world. Additionally, the site is prime for expansion, with 15 acres available for ground-up development and the option to further extend iBio’s facility by 125,000 to 175,000 square feet.

Savills’ Austin Barrett, Mark Cote, Lindsay Stroud and Allison Hoffman will oversee the strategy and sale process for iBio. The firm’s RJ Panzo and Tim Maynes will oversee lab and facility planning as the company evaluates its scientific needs.

“It is no secret that investment in the Texas Research Triangle has been robust with more than $400 million in funding secured by life sciences companies since 2018. As we understand this sector on the most granular levels, we are well-positioned to advise iBio on identifying an ideal partner that shares in the company’s long-term vision. We are expecting significant demand for this centrally located facility,” said Barrett.